

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | complement activation, alternative pathway (GO:0006957) | 5.74548288 |
| 2 | regulation of protein activation cascade (GO:2000257) | 5.50668119 |
| 3 | regulation of complement activation (GO:0030449) | 5.44369463 |
| 4 | * complement activation, classical pathway (GO:0006958) | 5.08359728 |
| 5 | * complement activation (GO:0006956) | 4.80004161 |
| 6 | regulation of plasminogen activation (GO:0010755) | 4.73135152 |
| 7 | protein heterotrimerization (GO:0070208) | 4.68214075 |
| 8 | exogenous drug catabolic process (GO:0042738) | 4.67463679 |
| 9 | regulation of fibrinolysis (GO:0051917) | 4.62311527 |
| 10 | negative regulation of fibrinolysis (GO:0051918) | 4.59846180 |
| 11 | ethanol oxidation (GO:0006069) | 4.58124532 |
| 12 | protein carboxylation (GO:0018214) | 4.54510508 |
| 13 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.54510508 |
| 14 | epoxygenase P450 pathway (GO:0019373) | 4.51928472 |
| 15 | omega-hydroxylase P450 pathway (GO:0097267) | 4.48852492 |
| 16 | * protein activation cascade (GO:0072376) | 4.41158042 |
| 17 | drug catabolic process (GO:0042737) | 4.38422689 |
| 18 | negative regulation of protein activation cascade (GO:2000258) | 4.20713219 |
| 19 | fibrinolysis (GO:0042730) | 4.14076584 |
| 20 | negative regulation of complement activation (GO:0045916) | 3.99111019 |
| 21 | virion attachment to host cell (GO:0019062) | 3.92772969 |
| 22 | adhesion of symbiont to host cell (GO:0044650) | 3.92772969 |
| 23 | regulation of apoptotic cell clearance (GO:2000425) | 3.91157377 |
| 24 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.74740633 |
| 25 | ethanol metabolic process (GO:0006067) | 3.70833392 |
| 26 | cell migration involved in heart development (GO:0060973) | 3.69430960 |
| 27 | keratan sulfate catabolic process (GO:0042340) | 3.68073778 |
| 28 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.64146100 |
| 29 | extracellular fibril organization (GO:0043206) | 3.64057199 |
| 30 | adhesion of symbiont to host (GO:0044406) | 3.64047567 |
| 31 | extracellular matrix assembly (GO:0085029) | 3.59651929 |
| 32 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.58829584 |
| 33 | collagen fibril organization (GO:0030199) | 3.56686307 |
| 34 | urea metabolic process (GO:0019627) | 3.49563300 |
| 35 | opsonization (GO:0008228) | 3.46244023 |
| 36 | blood coagulation, intrinsic pathway (GO:0007597) | 3.44995553 |
| 37 | negative regulation of blood coagulation (GO:0030195) | 3.41038594 |
| 38 | negative regulation of hemostasis (GO:1900047) | 3.41038594 |
| 39 | type B pancreatic cell proliferation (GO:0044342) | 3.40496545 |
| 40 | fibril organization (GO:0097435) | 3.32611398 |
| 41 | skin morphogenesis (GO:0043589) | 3.30323866 |
| 42 | drug metabolic process (GO:0017144) | 3.26951738 |
| 43 | negative regulation of coagulation (GO:0050819) | 3.24707082 |
| 44 | nitrogen cycle metabolic process (GO:0071941) | 3.24560944 |
| 45 | glyoxylate metabolic process (GO:0046487) | 3.23139863 |
| 46 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.20429536 |
| 47 | L-phenylalanine catabolic process (GO:0006559) | 3.20429536 |
| 48 | negative regulation of wound healing (GO:0061045) | 3.17502718 |
| 49 | regulation of humoral immune response (GO:0002920) | 3.17477104 |
| 50 | basement membrane organization (GO:0071711) | 3.14160524 |
| 51 | endodermal cell differentiation (GO:0035987) | 3.06302557 |
| 52 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.06108335 |
| 53 | L-phenylalanine metabolic process (GO:0006558) | 3.06108335 |
| 54 | acute-phase response (GO:0006953) | 3.05221224 |
| 55 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.04903853 |
| 56 | cellular glucuronidation (GO:0052695) | 3.03803284 |
| 57 | positive regulation of extracellular matrix organization (GO:1903055) | 3.02666416 |
| 58 | tooth mineralization (GO:0034505) | 3.01131718 |
| 59 | negative regulation of humoral immune response (GO:0002921) | 3.00651573 |
| 60 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.00271367 |
| 61 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.00271367 |
| 62 | urea cycle (GO:0000050) | 2.99436002 |
| 63 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.97208130 |
| 64 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.97117414 |
| 65 | blood vessel maturation (GO:0001955) | 2.95843628 |
| 66 | bile acid biosynthetic process (GO:0006699) | 2.91676221 |
| 67 | bile acid metabolic process (GO:0008206) | 2.90219229 |
| 68 | negative regulation of fatty acid transport (GO:2000192) | 2.88789931 |
| 69 | collagen metabolic process (GO:0032963) | 2.86052209 |
| 70 | uronic acid metabolic process (GO:0006063) | 2.84333832 |
| 71 | glucuronate metabolic process (GO:0019585) | 2.84333832 |
| 72 | regulation of triglyceride catabolic process (GO:0010896) | 2.84241184 |
| 73 | regulation of extracellular matrix disassembly (GO:0010715) | 2.80926031 |
| 74 | hormone catabolic process (GO:0042447) | 2.74776865 |
| 75 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.74609894 |
| 76 | bone trabecula formation (GO:0060346) | 2.72901709 |
| 77 | positive regulation of hemostasis (GO:1900048) | 2.72791259 |
| 78 | positive regulation of blood coagulation (GO:0030194) | 2.72791259 |
| 79 | regulation of phospholipase A2 activity (GO:0032429) | 2.71707761 |
| 80 | negative regulation of lipase activity (GO:0060192) | 2.71220915 |
| 81 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.68168363 |
| 82 | collagen catabolic process (GO:0030574) | 2.65005763 |
| 83 | multicellular organismal metabolic process (GO:0044236) | 2.64423604 |
| 84 | glomerular basement membrane development (GO:0032836) | 2.63541964 |
| 85 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.63497711 |
| 86 | negative regulation of cholesterol transport (GO:0032375) | 2.63485158 |
| 87 | negative regulation of sterol transport (GO:0032372) | 2.63485158 |
| 88 | metanephric mesenchyme development (GO:0072075) | 2.63317759 |
| 89 | bile acid and bile salt transport (GO:0015721) | 2.62825259 |
| 90 | extracellular matrix disassembly (GO:0022617) | 2.61616132 |
| 91 | glomerular filtration (GO:0003094) | 2.54525187 |
| 92 | barbed-end actin filament capping (GO:0051016) | 2.52818519 |
| 93 | multicellular organismal catabolic process (GO:0044243) | 2.52689906 |
| 94 | positive regulation of coagulation (GO:0050820) | 2.52312625 |
| 95 | dermatan sulfate metabolic process (GO:0030205) | 2.49360285 |
| 96 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.48029371 |
| 97 | positive regulation of lipid catabolic process (GO:0050996) | 2.46587719 |
| 98 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.46374331 |
| 99 | dermatan sulfate biosynthetic process (GO:0030208) | 2.45287173 |
| 100 | hyaluronan catabolic process (GO:0030214) | 2.45178887 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.57352595 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.55118124 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 4.16699922 |
| 4 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 3.82799552 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.14242903 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.92436283 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.84986372 |
| 8 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.64538572 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.62000970 |
| 10 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.60325844 |
| 11 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.55298089 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.34228831 |
| 13 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.20238822 |
| 14 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.15134272 |
| 15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.13480789 |
| 16 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.12881592 |
| 17 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.09396826 |
| 18 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.08108522 |
| 19 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.95422006 |
| 20 | CJUN_26792858_Chip-Seq_BT549_Human | 1.69597607 |
| 21 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.69045417 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.61423357 |
| 23 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.56071483 |
| 24 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.55823895 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.55658475 |
| 26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.54713793 |
| 27 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.51509454 |
| 28 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.49878456 |
| 29 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.49306067 |
| 30 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.48058173 |
| 31 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.45038369 |
| 32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.42190538 |
| 33 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.37552882 |
| 34 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.34788956 |
| 35 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.32866352 |
| 36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.31108557 |
| 37 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.28700563 |
| 38 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.28700563 |
| 39 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.28103320 |
| 40 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.25731329 |
| 41 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.25272583 |
| 42 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.24054078 |
| 43 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.21187956 |
| 44 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.20368624 |
| 45 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.20368624 |
| 46 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.18916349 |
| 47 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18184523 |
| 48 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.17262085 |
| 49 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.17030239 |
| 50 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.15615865 |
| 51 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.12546752 |
| 52 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.10598451 |
| 53 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.10213481 |
| 54 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.10106829 |
| 55 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.10061894 |
| 56 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.09548698 |
| 57 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.09081563 |
| 58 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.09081563 |
| 59 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.08598999 |
| 60 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.08511713 |
| 61 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.07349112 |
| 62 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.04894113 |
| 63 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.04014438 |
| 64 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.03445713 |
| 65 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.03152438 |
| 66 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.00610513 |
| 67 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.99542871 |
| 68 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.98770172 |
| 69 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.97926164 |
| 70 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.97624444 |
| 71 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97233408 |
| 72 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96464333 |
| 73 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.94814177 |
| 74 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94612411 |
| 75 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.94485398 |
| 76 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.93666559 |
| 77 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.93270051 |
| 78 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93198565 |
| 79 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.92213994 |
| 80 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.90541919 |
| 81 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.90465568 |
| 82 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.89792876 |
| 83 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.89477673 |
| 84 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.89264545 |
| 85 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.87677669 |
| 86 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.87519014 |
| 87 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87044996 |
| 88 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.86334259 |
| 89 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.86162467 |
| 90 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.84549173 |
| 91 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.83921722 |
| 92 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.83784090 |
| 93 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.83719930 |
| 94 | TP53_16413492_ChIP-PET_HCT116_Human | 0.82852383 |
| 95 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.82508629 |
| 96 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82189417 |
| 97 | KDM2B_26808549_Chip-Seq_K562_Human | 0.81982444 |
| 98 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.80504746 |
| 99 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.80504746 |
| 100 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.78803518 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 7.28959051 |
| 2 | MP0005503_abnormal_tendon_morphology | 5.53664891 |
| 3 | MP0005275_abnormal_skin_tensile | 4.99213283 |
| 4 | MP0001958_emphysema | 3.64223509 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 3.54956075 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 3.39228878 |
| 7 | MP0003279_aneurysm | 3.34766432 |
| 8 | MP0004272_abnormal_basement_membrane | 3.11629312 |
| 9 | MP0010368_abnormal_lymphatic_system | 2.69470823 |
| 10 | MP0005360_urolithiasis | 2.57871721 |
| 11 | MP0005257_abnormal_intraocular_pressure | 2.51556683 |
| 12 | MP0006054_spinal_hemorrhage | 2.35882187 |
| 13 | MP0005365_abnormal_bile_salt | 2.26338462 |
| 14 | MP0005085_abnormal_gallbladder_physiolo | 2.15390319 |
| 15 | MP0005023_abnormal_wound_healing | 1.97651577 |
| 16 | MP0000751_myopathy | 1.96851418 |
| 17 | MP0001542_abnormal_bone_strength | 1.92937607 |
| 18 | MP0009840_abnormal_foam_cell | 1.89910650 |
| 19 | MP0002295_abnormal_pulmonary_circulatio | 1.85598280 |
| 20 | MP0002108_abnormal_muscle_morphology | 1.84205800 |
| 21 | MP0005508_abnormal_skeleton_morphology | 1.78636967 |
| 22 | MP0009384_cardiac_valve_regurgitation | 1.78312712 |
| 23 | MP0002060_abnormal_skin_morphology | 1.72980931 |
| 24 | MP0008875_abnormal_xenobiotic_pharmacok | 1.71233961 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 1.63470596 |
| 26 | MP0003566_abnormal_cell_adhesion | 1.59763085 |
| 27 | MP0003252_abnormal_bile_duct | 1.49655969 |
| 28 | MP0000767_abnormal_smooth_muscle | 1.49388056 |
| 29 | MP0002933_joint_inflammation | 1.43972887 |
| 30 | MP0004858_abnormal_nervous_system | 1.34518865 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 1.33091832 |
| 32 | MP0003091_abnormal_cell_migration | 1.31303814 |
| 33 | MP0001243_abnormal_dermal_layer | 1.23372401 |
| 34 | MP0005670_abnormal_white_adipose | 1.23044358 |
| 35 | MP0002896_abnormal_bone_mineralization | 1.22783339 |
| 36 | MP0005164_abnormal_response_to | 1.22773089 |
| 37 | MP0002254_reproductive_system_inflammat | 1.20657043 |
| 38 | MP0003868_abnormal_feces_composition | 1.20512011 |
| 39 | MP0005390_skeleton_phenotype | 1.19503714 |
| 40 | MP0005595_abnormal_vascular_smooth | 1.18978426 |
| 41 | MP0001666_abnormal_nutrient_absorption | 1.18804300 |
| 42 | MP0010329_abnormal_lipoprotein_level | 1.14450457 |
| 43 | MP0000604_amyloidosis | 1.14326165 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.10533504 |
| 45 | MP0005058_abnormal_lysosome_morphology | 1.05066084 |
| 46 | MP0003011_delayed_dark_adaptation | 1.00068438 |
| 47 | MP0003724_increased_susceptibility_to | 0.99948313 |
| 48 | MP0001879_abnormal_lymphatic_vessel | 0.99412748 |
| 49 | MP0001661_extended_life_span | 0.99318070 |
| 50 | MP0001533_abnormal_skeleton_physiology | 0.98767495 |
| 51 | MP0000013_abnormal_adipose_tissue | 0.96874220 |
| 52 | MP0003195_calcinosis | 0.93527323 |
| 53 | MP0002998_abnormal_bone_remodeling | 0.92076969 |
| 54 | MP0002249_abnormal_larynx_morphology | 0.87552736 |
| 55 | MP0008004_abnormal_stomach_pH | 0.86628222 |
| 56 | MP0000249_abnormal_blood_vessel | 0.86529001 |
| 57 | MP0004883_abnormal_blood_vessel | 0.86275801 |
| 58 | MP0003329_amyloid_beta_deposits | 0.84734308 |
| 59 | MP0002971_abnormal_brown_adipose | 0.84073474 |
| 60 | MP0005332_abnormal_amino_acid | 0.84037460 |
| 61 | MP0010352_gastrointestinal_tract_polyps | 0.81188602 |
| 62 | MP0009780_abnormal_chondrocyte_physiolo | 0.79288521 |
| 63 | MP0000163_abnormal_cartilage_morphology | 0.78927210 |
| 64 | MP0003950_abnormal_plasma_membrane | 0.78518827 |
| 65 | MP0002128_abnormal_blood_circulation | 0.77803991 |
| 66 | MP0005388_respiratory_system_phenotype | 0.77513655 |
| 67 | MP0002133_abnormal_respiratory_system | 0.77513655 |
| 68 | MP0000343_altered_response_to | 0.74840486 |
| 69 | MP0002282_abnormal_trachea_morphology | 0.74622180 |
| 70 | MP0000467_abnormal_esophagus_morphology | 0.74560837 |
| 71 | MP0002168_other_aberrant_phenotype | 0.73947307 |
| 72 | MP0002876_abnormal_thyroid_physiology | 0.73229383 |
| 73 | MP0003448_altered_tumor_morphology | 0.71860591 |
| 74 | MP0005409_darkened_coat_color | 0.71691245 |
| 75 | MP0004019_abnormal_vitamin_homeostasis | 0.71555751 |
| 76 | MP0009053_abnormal_anal_canal | 0.70576230 |
| 77 | MP0001849_ear_inflammation | 0.70096115 |
| 78 | MP0002115_abnormal_skeleton_extremities | 0.68928355 |
| 79 | MP0005165_increased_susceptibility_to | 0.68615180 |
| 80 | MP0005623_abnormal_meninges_morphology | 0.68583484 |
| 81 | MP0003941_abnormal_skin_development | 0.66894631 |
| 82 | MP0009250_abnormal_appendicular_skeleto | 0.66651649 |
| 83 | MP0001915_intracranial_hemorrhage | 0.66296145 |
| 84 | MP0006138_congestive_heart_failure | 0.65699548 |
| 85 | MP0010386_abnormal_urinary_bladder | 0.65035163 |
| 86 | MP0000462_abnormal_digestive_system | 0.64870387 |
| 87 | MP0002118_abnormal_lipid_homeostasis | 0.64453784 |
| 88 | MP0001348_abnormal_lacrimal_gland | 0.61472142 |
| 89 | MP0001614_abnormal_blood_vessel | 0.60968014 |
| 90 | MP0000681_abnormal_thyroid_gland | 0.56601629 |
| 91 | MP0000003_abnormal_adipose_tissue | 0.56312618 |
| 92 | MP0000609_abnormal_liver_physiology | 0.56147378 |
| 93 | MP0000534_abnormal_ureter_morphology | 0.56049893 |
| 94 | MP0003795_abnormal_bone_structure | 0.55408367 |
| 95 | MP0005197_abnormal_uvea_morphology | 0.55014467 |
| 96 | MP0001175_abnormal_lung_morphology | 0.54902635 |
| 97 | MP0003115_abnormal_respiratory_system | 0.54448798 |
| 98 | MP0004782_abnormal_surfactant_physiolog | 0.51768132 |
| 99 | MP0003186_abnormal_redox_activity | 0.50843981 |
| 100 | MP0002113_abnormal_skeleton_development | 0.50554915 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 6.89032785 |
| 2 | Systemic lupus erythematosus (HP:0002725) | 6.08692682 |
| 3 | Premature rupture of membranes (HP:0001788) | 5.90062154 |
| 4 | * Complement deficiency (HP:0004431) | 5.89933101 |
| 5 | * Abnormality of complement system (HP:0005339) | 5.62177271 |
| 6 | Aortic aneurysm (HP:0004942) | 4.78816773 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.35070996 |
| 8 | Aortic dissection (HP:0002647) | 4.35009456 |
| 9 | Vascular tortuosity (HP:0004948) | 4.20639649 |
| 10 | Ankle contracture (HP:0006466) | 4.14499057 |
| 11 | Deep venous thrombosis (HP:0002625) | 3.88860970 |
| 12 | Broad metatarsal (HP:0001783) | 3.83590610 |
| 13 | Follicular hyperkeratosis (HP:0007502) | 3.75998737 |
| 14 | Glomerulonephritis (HP:0000099) | 3.75884644 |
| 15 | Soft skin (HP:0000977) | 3.71136980 |
| 16 | Bladder diverticulum (HP:0000015) | 3.64368028 |
| 17 | Type 1 muscle fiber predominance (HP:0003803) | 3.61011970 |
| 18 | Vertebral compression fractures (HP:0002953) | 3.58538129 |
| 19 | Cervical subluxation (HP:0003308) | 3.54566837 |
| 20 | Arterial tortuosity (HP:0005116) | 3.35426740 |
| 21 | Wormian bones (HP:0002645) | 3.19462068 |
| 22 | Atrophic scars (HP:0001075) | 3.10739609 |
| 23 | Peritonitis (HP:0002586) | 3.07991398 |
| 24 | Neonatal short-limb short stature (HP:0008921) | 3.01444315 |
| 25 | Dilatation of the ascending aorta (HP:0005111) | 2.98797051 |
| 26 | Mitral stenosis (HP:0001718) | 2.96240770 |
| 27 | Fragile skin (HP:0001030) | 2.94543534 |
| 28 | Shallow orbits (HP:0000586) | 2.93907771 |
| 29 | Spinal rigidity (HP:0003306) | 2.93447549 |
| 30 | Blue sclerae (HP:0000592) | 2.92366683 |
| 31 | Prolonged partial thromboplastin time (HP:0003645) | 2.91830173 |
| 32 | Cerebral aneurysm (HP:0004944) | 2.91658999 |
| 33 | Slender build (HP:0001533) | 2.90590726 |
| 34 | Increased variability in muscle fiber diameter (HP:0003557) | 2.87944845 |
| 35 | Wrist flexion contracture (HP:0001239) | 2.76666585 |
| 36 | Biconcave vertebral bodies (HP:0004586) | 2.76319802 |
| 37 | Joint hemorrhage (HP:0005261) | 2.63650900 |
| 38 | Abnormality of dentin (HP:0010299) | 2.63481408 |
| 39 | * Nephritis (HP:0000123) | 2.63261919 |
| 40 | Aneurysm (HP:0002617) | 2.63124842 |
| 41 | Hyperlipoproteinemia (HP:0010980) | 2.58762871 |
| 42 | Abnormal delivery (HP:0001787) | 2.56260288 |
| 43 | Increased connective tissue (HP:0009025) | 2.55819405 |
| 44 | Conjugated hyperbilirubinemia (HP:0002908) | 2.55633051 |
| 45 | Spondylolisthesis (HP:0003302) | 2.53990436 |
| 46 | Xanthomatosis (HP:0000991) | 2.49244649 |
| 47 | Mitral valve prolapse (HP:0001634) | 2.47784876 |
| 48 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.47430497 |
| 49 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.47058208 |
| 50 | Joint stiffness (HP:0001387) | 2.45253461 |
| 51 | Genu recurvatum (HP:0002816) | 2.45199585 |
| 52 | Osteolytic defects of the hand bones (HP:0009699) | 2.43637724 |
| 53 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.43637724 |
| 54 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.37158115 |
| 55 | Aortic regurgitation (HP:0001659) | 2.36656982 |
| 56 | Joint laxity (HP:0001388) | 2.36467113 |
| 57 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.33665888 |
| 58 | Hyperextensible skin (HP:0000974) | 2.31781789 |
| 59 | Overgrowth (HP:0001548) | 2.27242863 |
| 60 | Emphysema (HP:0002097) | 2.20773288 |
| 61 | Aortic valve stenosis (HP:0001650) | 2.19964611 |
| 62 | Hypobetalipoproteinemia (HP:0003563) | 2.18699239 |
| 63 | Bowel diverticulosis (HP:0005222) | 2.18077952 |
| 64 | Abnormality of the acetabulum (HP:0003170) | 2.15240591 |
| 65 | Cardiovascular calcification (HP:0011915) | 2.15196165 |
| 66 | Wide anterior fontanel (HP:0000260) | 2.13328385 |
| 67 | Intrahepatic cholestasis (HP:0001406) | 2.12155903 |
| 68 | Mitral regurgitation (HP:0001653) | 2.06481180 |
| 69 | Nonimmune hydrops fetalis (HP:0001790) | 2.04003557 |
| 70 | Hypoalphalipoproteinemia (HP:0003233) | 2.02780952 |
| 71 | Ectopia lentis (HP:0001083) | 1.98775566 |
| 72 | Pulmonary artery stenosis (HP:0004415) | 1.98301421 |
| 73 | Coronal craniosynostosis (HP:0004440) | 1.97306882 |
| 74 | Striae distensae (HP:0001065) | 1.96724253 |
| 75 | Abnormality of the intrinsic pathway (HP:0010989) | 1.95484319 |
| 76 | Persistence of primary teeth (HP:0006335) | 1.91107936 |
| 77 | Abnormality of the common coagulation pathway (HP:0010990) | 1.90341376 |
| 78 | Ovoid vertebral bodies (HP:0003300) | 1.88940326 |
| 79 | Skin nodule (HP:0200036) | 1.88552778 |
| 80 | Hemorrhage of the eye (HP:0011885) | 1.87251490 |
| 81 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.86113317 |
| 82 | Hypoventilation (HP:0002791) | 1.85224545 |
| 83 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.85020461 |
| 84 | Mucopolysacchariduria (HP:0008155) | 1.85020461 |
| 85 | Abnormality of proline metabolism (HP:0010907) | 1.84524062 |
| 86 | Hydroxyprolinuria (HP:0003080) | 1.84524062 |
| 87 | Hypolipoproteinemia (HP:0010981) | 1.84052611 |
| 88 | Coxa vara (HP:0002812) | 1.83767158 |
| 89 | Elbow flexion contracture (HP:0002987) | 1.83652886 |
| 90 | Round ear (HP:0100830) | 1.81997092 |
| 91 | Osteoarthritis (HP:0002758) | 1.81229800 |
| 92 | Gingival overgrowth (HP:0000212) | 1.80476519 |
| 93 | Ulnar bowing (HP:0003031) | 1.79283817 |
| 94 | Abnormality of the Achilles tendon (HP:0005109) | 1.78657555 |
| 95 | Generalized amyotrophy (HP:0003700) | 1.78028442 |
| 96 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.75383986 |
| 97 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.75383986 |
| 98 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.75383986 |
| 99 | Turricephaly (HP:0000262) | 1.75092149 |
| 100 | Mild short stature (HP:0003502) | 1.74779674 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.70700003 |
| 2 | MYLK | 4.41895562 |
| 3 | PDGFRA | 3.91571170 |
| 4 | RIPK1 | 3.33995093 |
| 5 | DDR2 | 3.30365141 |
| 6 | TRIB3 | 2.49356599 |
| 7 | FGFR4 | 2.39190891 |
| 8 | TGFBR2 | 2.36395154 |
| 9 | EPHA3 | 2.14098876 |
| 10 | SIK1 | 2.12917413 |
| 11 | EPHB2 | 2.07219568 |
| 12 | CDC42BPA | 2.06412007 |
| 13 | KIT | 1.99968342 |
| 14 | TTN | 1.94619001 |
| 15 | EPHB1 | 1.90294198 |
| 16 | NEK9 | 1.78998302 |
| 17 | TYK2 | 1.71396613 |
| 18 | NTRK1 | 1.67611300 |
| 19 | TESK1 | 1.63551552 |
| 20 | JAK1 | 1.60428819 |
| 21 | MAP3K6 | 1.59374256 |
| 22 | PDGFRB | 1.53937562 |
| 23 | PAK2 | 1.53385648 |
| 24 | LATS2 | 1.49422364 |
| 25 | PTK2 | 1.48173503 |
| 26 | ABL2 | 1.43130640 |
| 27 | PRPF4B | 1.40063158 |
| 28 | MST1R | 1.34321374 |
| 29 | PRKD2 | 1.33481150 |
| 30 | PIK3CG | 1.32156108 |
| 31 | MAPK7 | 1.25400066 |
| 32 | MET | 1.23943535 |
| 33 | AKT3 | 1.18845018 |
| 34 | MAP3K3 | 1.12846316 |
| 35 | LATS1 | 1.11564719 |
| 36 | GRK1 | 1.09527419 |
| 37 | GRK5 | 1.08258791 |
| 38 | FGFR3 | 1.01990579 |
| 39 | PAK4 | 1.01118593 |
| 40 | STK38 | 0.98611770 |
| 41 | ADRBK1 | 0.91323006 |
| 42 | DMPK | 0.90644236 |
| 43 | FER | 0.88815876 |
| 44 | NLK | 0.85931644 |
| 45 | MAPKAPK3 | 0.84809358 |
| 46 | TRPM7 | 0.81911640 |
| 47 | MAP3K7 | 0.81222191 |
| 48 | TBK1 | 0.80886898 |
| 49 | PRKG2 | 0.75340225 |
| 50 | PKN2 | 0.74682213 |
| 51 | LIMK1 | 0.74326213 |
| 52 | ZAP70 | 0.74323550 |
| 53 | RPS6KA2 | 0.73601482 |
| 54 | PRKD1 | 0.72250775 |
| 55 | MTOR | 0.71932070 |
| 56 | TIE1 | 0.71773234 |
| 57 | JAK3 | 0.71722309 |
| 58 | ROCK1 | 0.65146356 |
| 59 | HIPK2 | 0.63719337 |
| 60 | LMTK2 | 0.62737880 |
| 61 | ERBB4 | 0.62438418 |
| 62 | PIK3CA | 0.62438048 |
| 63 | ROCK2 | 0.61964568 |
| 64 | DAPK3 | 0.61101832 |
| 65 | MARK2 | 0.59336906 |
| 66 | RET | 0.57252945 |
| 67 | PDPK1 | 0.57146711 |
| 68 | MAPK4 | 0.56314869 |
| 69 | GSK3A | 0.55389758 |
| 70 | CAMK2G | 0.53811560 |
| 71 | SMG1 | 0.53415741 |
| 72 | PRKAA2 | 0.53044924 |
| 73 | ICK | 0.52864693 |
| 74 | ILK | 0.52634249 |
| 75 | EEF2K | 0.51679984 |
| 76 | PTK2B | 0.50794709 |
| 77 | MAP3K1 | 0.50789550 |
| 78 | FLT3 | 0.50130351 |
| 79 | GRK6 | 0.48620572 |
| 80 | RPS6KC1 | 0.47315423 |
| 81 | RPS6KL1 | 0.47315423 |
| 82 | MAPK11 | 0.46351673 |
| 83 | MAPK12 | 0.45706361 |
| 84 | PTK6 | 0.45595883 |
| 85 | BMX | 0.44272484 |
| 86 | SRC | 0.43206298 |
| 87 | EPHA2 | 0.40489831 |
| 88 | KSR2 | 0.39982572 |
| 89 | MAP2K1 | 0.39873206 |
| 90 | GRK7 | 0.39353883 |
| 91 | MAP2K3 | 0.39293382 |
| 92 | PIM2 | 0.39289211 |
| 93 | ADRBK2 | 0.38193360 |
| 94 | PRKACG | 0.38005918 |
| 95 | MELK | 0.37699950 |
| 96 | TGFBR1 | 0.37541808 |
| 97 | JAK2 | 0.34998008 |
| 98 | MAP3K2 | 0.34703629 |
| 99 | TAOK2 | 0.34120428 |
| 100 | RPS6KA6 | 0.33300402 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.40911545 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.10992975 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.04276350 |
| 4 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.86570286 |
| 5 | Retinol metabolism_Homo sapiens_hsa00830 | 2.83038326 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.53707916 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.53144914 |
| 8 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.40874388 |
| 9 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.32665482 |
| 10 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.23661570 |
| 11 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.21156747 |
| 12 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.16643989 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.12343539 |
| 14 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.07917601 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.07510158 |
| 16 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.05870050 |
| 17 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.04639734 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 2.03157641 |
| 19 | Prion diseases_Homo sapiens_hsa05020 | 1.92966568 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.88833244 |
| 21 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.70870335 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.67593382 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.63647279 |
| 24 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.63582073 |
| 25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.49260096 |
| 26 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.44861078 |
| 27 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.44505542 |
| 28 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.39735598 |
| 29 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.33735133 |
| 30 | Focal adhesion_Homo sapiens_hsa04510 | 1.29256519 |
| 31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.27228618 |
| 32 | Amoebiasis_Homo sapiens_hsa05146 | 1.24293963 |
| 33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22710413 |
| 34 | * Pertussis_Homo sapiens_hsa05133 | 1.05881439 |
| 35 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.98470104 |
| 36 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96961317 |
| 37 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.96903944 |
| 38 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.92845076 |
| 39 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.88424865 |
| 40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84056558 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 0.84043737 |
| 42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.83263234 |
| 43 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.83110526 |
| 44 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.80081333 |
| 45 | Malaria_Homo sapiens_hsa05144 | 0.79656451 |
| 46 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.79452832 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.74141154 |
| 48 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.69087057 |
| 49 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.66890887 |
| 50 | Mineral absorption_Homo sapiens_hsa04978 | 0.63693976 |
| 51 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.61131042 |
| 52 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.58323548 |
| 53 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.57674297 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.57623963 |
| 55 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.56781509 |
| 56 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.54196484 |
| 57 | Peroxisome_Homo sapiens_hsa04146 | 0.54046685 |
| 58 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52744329 |
| 59 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.52660589 |
| 60 | Insulin resistance_Homo sapiens_hsa04931 | 0.51938794 |
| 61 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.50770903 |
| 62 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.49500307 |
| 63 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.48917319 |
| 64 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45696241 |
| 65 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45599433 |
| 66 | Lysosome_Homo sapiens_hsa04142 | 0.45172440 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.44833944 |
| 68 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43598099 |
| 69 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.43078164 |
| 70 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.41443385 |
| 71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.38926150 |
| 72 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.35783306 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.33389727 |
| 74 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.32858041 |
| 75 | Carbon metabolism_Homo sapiens_hsa01200 | 0.32606816 |
| 76 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.31168954 |
| 77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28289112 |
| 78 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.26831046 |
| 79 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.26104974 |
| 80 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.25557379 |
| 81 | Lysine degradation_Homo sapiens_hsa00310 | 0.23968976 |
| 82 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.23202390 |
| 83 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.21512419 |
| 84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.21456163 |
| 85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.21183187 |
| 86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.19994872 |
| 87 | Melanoma_Homo sapiens_hsa05218 | 0.19613594 |
| 88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.19226534 |
| 89 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.17924052 |
| 90 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.17868826 |
| 91 | Adherens junction_Homo sapiens_hsa04520 | 0.17504590 |
| 92 | Bladder cancer_Homo sapiens_hsa05219 | 0.16424820 |
| 93 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.15992776 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.15943161 |
| 95 | * Phagosome_Homo sapiens_hsa04145 | 0.15889502 |
| 96 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.15370776 |
| 97 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.15084846 |
| 98 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.14662768 |
| 99 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.14374159 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.14370430 |

